Abstract. Repeated selective population chemotherapy of school age children reduces infection and morbidity associated with Schistosoma haematobium infection. To examine the long-term effect of this treatment on susceptibility to re-infection and late disease, a cohort of Kenyans (n ϭ 194) were re-examined for infection and urinary tract morbidity 7-13 years after they underwent annual ultrasonography and treatment for an average of 5 years beginning in 1984 as children. Controls were previously untreated age-matched individuals residing in the same or adjacent villages. The overall prevalence and intensity of infection were equivalent between the 2 groups. In contrast, the prevalence of bladder wall pathology was 11-fold lower in previously treated (1.5%) versus untreated subjects (17%). Severe hydronephrosis was completely reversed. These data demonstrate that treatment significantly reduced urinary tract morbidity despite re-infection, and suggest that the important risk factors for urinary tract morbidity in adulthood are cumulative intensity and duration of infection during early adolescence.Schistosoma haematobium infection affects more than 90 million people worldwide, representing a major health problem in central and southern Africa and the eastern Mediterranean. In urinary schistosomiasis, adult female worms deposit their eggs into the lower urinary tract from the pelvic venous plexus and mesenteric veins. The pathology of urinary schistosomiasis results from host granulomatous inflammatory response to eggs trapped in the bladder, ureters, and other pelvic structures. Consequent urinary tract injury manifests as hematuria, proteinuria, bladder wall thickening, and bladder irregularities (e.g., polyps, calcifications), and a predisposition to squamous cells carcinoma of the bladder.